The rights to an alleged AIDS remedy that sparked political and scientific controversy last year have been sold to a Black business consortium that is determined to get it to the market. The consortium, called Virodene Pharmaceutical Holdings, bought the majority interest in cryopreservation technologies that developed Virodene P058.